A team of researchers at the Vanderbilt Vaccine Center selects lead antibody candidates for further screening.

COVID-19

PRI audio player

Doctors in China and the US have transfused antibodies from recovered patients directly into the blood of people with severe cases of COVID-19. Dr. Mario Ostrowski and his collaborators want to identify the genes that encode these antibodies and use them to mass produce lab-grown versions — to turn into a drug to treat the infection.

Player utilities

Read the full story at TheWorld.org.

A team of researchers at the Vanderbilt Vaccine Center selects lead antibody candidates for further screening.

Credit:

Rachel Nargi

Related Content

close

We use cookies to understand how you use our site and to improve your experience. To learn more, review our Cookie Policy. By continuing to use our site, you accept our use of cookies and Privacy Policy.

Ok, I understand. Close
close

The story you just read is freely available and accessible to everyone because readers like you support The World financially. 

Thank you all for helping us reach our goal of 1,000 donors. We couldn’t have done it without your support. Your donation directly supported the critical reporting you rely on, the consistent reporting you believe in, and the deep reporting you want to ensure survives. 

DONATE TODAY > No thanks